R.V. Ward et al., J. Biochem., vol. 278, “The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex,” pp. 179-187 (1991). |
Y. Okada et al., Eur J. Biochem., vol. 194, Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts (Purification and activation of the precursor and enzymic properties), pp. 721-730 (1990). |
Y. Okada et al., J. Bio. Chem., vol. 267, No. 30, “Matrix Metalloproteinase 9 (92-kDa Gelatinase/Type IV Collagenase) from HT 1080 Human Fibrosarcoma Cells,” pp. 21712-21719 (1992). |
C.G. Knight et al., FEBS, vol. 296, No. 3, “A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases,” pp. 263-266 (1992). |
J.J.N., vol. 36, p. 106 (1994). |
J.J.N., vol. 39, p. 220 (1997). |
J.J.N., vol. 39, p. 300 (1997). |
Albert Wolthuis et al., Am. J. Pathol., vol. 143, No. 4, “Cell Density Modulates Growth, Extracellular Matrix, and Protein Synthesis of Cultured Rat Mesangial Cells,” pp. 1209-1219 (1993). |
Yoshinori Tamura et al., J. Med. Chem., vol. 41, No. 4, “Highly Selective and Orally Active Inhibitors of type IV Collagenase (MMP-9 and MMP-2); N-Sulfonylamino Acid Derivatives,” pp. 640-649 (1998). |